Synthon receives European approvals for Rosuvastatin

23-Jan-2012 - Netherlands

Synthon announced today that it has successfully concluded multiple registration procedures for Rosuvastatin 5mg, 10mg, 15mg, 20mg and 40mg film-coated immediate release tablets. Regulatory clearance for Rosuvastatin has been obtained in 14 European countries.

Other news from the department research and development

Most read news

More news from our other portals

All FT-IR spectrometer manufacturers at a glance